+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.

All AgesAll Genders
305 locations
S

Actively Recruiting

Researchers are evaluating whether shortening the healing time between extraction socket preservation and implant placement improves clinical and radiographic outcomes compared to the usual longer waiting period. This randomized controlled clinical trial involves adults needing single-tooth extraction and implant therapy using the Vega Plus implant system. The study aims to optimize treatment timing and improve efficiency while maintaining positive clinical results. Participants will be randomly assigned to receive implant placement either 4 months reduced interval or 6 months standard interval after ridge preservation. Both groups undergo treatment with the Vega Plus implants. Clinical examinations and imaging will be conducted at baseline and follow-up visits to assess differences between the two timing protocols. Throughout the trial, participants will have clinical and radiographic assessments including cone-beam computed tomography CBCT to measure changes in alveolar ridge width and bone height. Implant stability, marginal bone levels, and postoperative pain will also be monitored. Follow-up extends to two years post-prosthetic loading, providing detailed data on treatment outcomes and safety.

Age: 18Years +All GendersPhase Not Applicable
1 location
O

Actively Recruiting

Healthy Volunteer

This research collects extensive clinical data to evaluate the Willem AI platforms performance in interpreting electrocardiograms ECGs from high-risk cardiac patients in real-world healthcare settings. Cardiovascular diseases pose significant public health challenges, and while ECGs are valuable for early detection, their interpretation can be complex, costly, and time-consuming for cardiology experts. Previous trials have assessed Willems AI-based interpretation, but this study aims to gather additional evidence to support its integration into routine care. Participants include high-risk cardiac patients undergoing routine ECGs for arrhythmia or cardiac disease assessment. Enrollment is both retrospective and prospective, with Willem analyzing ECGs automatically without influencing clinical decisions or altering standard care. The platform processes various ECG types and formats, including 12-lead ECGs and recordings from Holters, wearables, and other devices, with specific technical requirements for data quality and length. Participants contribute clinical data and ECG recordings which Willem evaluates for cardiac abnormalities over a period that may extend up to 10 years for prospective cases. The study tracks Willems diagnostic performance compared to standard care ECG evaluations. No interventions alter patient care, and the study focuses on collecting comprehensive data to assess AI interpretation accuracy and utility in clinical practice.

Age: 18Years +All Genders
5 locations
E

Actively Recruiting

Achalasia is a disorder where the esophagus has trouble moving food down because the lower esophageal sphincter LES does not relax properly. Patients often experience worsening swallowing difficulties, along with symptoms like nighttime cough, heartburn, weight loss, and food regurgitation. Diagnosis usually involves tests like esophageal imaging, endoscopy, and manometry, with the Eckardt Symptom Score ESS used to judge the severity and treatment effect. This trial aims to assess a new device designed to improve a minimally invasive treatment called per-oral endoscopic myotomy POEM in patients with achalasia. The study evaluates the safety and effectiveness of a novel SpydrBlade Flex device, which uses radiofrequency and microwave ablation technology for the POEM procedure. This device may be used with either the anterior or posterior POEM approach, depending on the patients condition and the doctors preference. The treatment involves creating a tunnel in the esophagus lining and cutting muscle to reduce LES pressure, helping food pass into the stomach more easily. Participants will undergo the POEM procedure using this new device. Researchers will monitor several outcomes, including the technical success of the procedure within one day and clinical symptom improvement after 30 days. Safety will be tracked by noting any complications during and after the operation. Additional assessments of reflux symptoms, esophageal function, and quality of life will be done up to six months post-procedure. The total study duration allows for follow-up to ensure safety and measure longer-term effects.

Age: 18Years +All GendersPhase Not Applicable
2 locations